Wi
Windlas Bio
Dehradun INFounded 20012,500 employees
Private CappharmaPrivateOncology
Platform: CDMO India
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rimavorutinib | WIN-7623 | Phase 1 | 2 | RET | OCD | ||
| Pemizasiran | WIN-1835 | NDA/BLA | 2 | GLP-1R | GBM | ||
| Riboinavolisib | WIN-8378 | Phase 2 | 2 | CD38 | MDD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)